• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Xoma Royalty Corporation (NQ: XOMA )

    29.75 +0.61 (+2.09%)
    Streaming Delayed Price Updated: 10:40 AM EDT, Aug 27, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Xoma Royalty Corporation

    < Previous 1 2 Next >
    XOMA Stock Earnings: XOMA Misses EPS, Beats Revenue for Q2 2024
    XOMA stock results show that XOMA missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    FDA Convenes Expert Panel Meeting For Zevra Therapeutics' Arimoclomol, Analyst Optimistic About Approval Despite Small Patient Base
    FDA's Genetic Metabolic Diseases Advisory Committee will review Zevra Therapeutics' arimoclomol for Niemann-Pick disease type C on August 2. PDUFA decision expected by September 21. 
    Via Benzinga
    Exposures Product Safety
    Demystifying XOMA: Insights From 5 Analyst Reviews
    Via Benzinga
    3 Crazy Good Stocks to Buy With $500 Right Now
    For investors with only a little money to spare, these three supercharged stocks represent an outrageous opportunity for future growth. 
    Via InvestorPlace
    Peeling Back The Layers: Exploring XOMA Through Analyst Insights
    Via Benzinga
    XOMA Stock Earnings: XOMA Misses EPS, Beats Revenue for Q1 2024
    XOMA stock results show that XOMA missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Cracking The Code: Understanding Analyst Reviews For XOMA
    Via Benzinga
    Recap: XOMA Q4 Earnings
    Via Benzinga
    XOMA's Return On Capital Employed Insights
    Via Benzinga
    XOMA Stock Earnings: XOMA Misses EPS, Misses Revenue for Q4 2023
    XOMA stock results show that XOMA missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
    Via InvestorPlace
    Biotech Royalty Aggregator XOMA To Acquire Small Cancer-Drug Developer Kinnate Biopharma
    XOMA acquires Kinnate Biopharma for $2.3352 per share, with potential additional cash. The acquisition is expected to close in April 2024. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
      On Friday, 57 companies reached new 52-week lows. 
    Via Benzinga
    XOMA Earnings Perspective: Return On Capital Employed
    Via Benzinga
    XOMA's Return On Capital Employed Insights
    Via Benzinga
    Starbucks And 3 Other Stock Insiders Are Buying
    Although US stocks closed lower on Friday, there were a few notable insider trades. 
    Via Benzinga
    Recap: XOMA Q4 Earnings
    XOMA (NASDAQ:XOMA) reported its Q4 earnings results on Tuesday, March 8, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings XOMA... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Monday
      During Monday, 102 stocks hit new 52-week lows. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Thursday
      During Thursday, 56 stocks hit new 52-week lows. 
    Via Benzinga
    Arimoclomol and Aldoxorubicin Acquisition to Bolster XOMA's Revenue Growth: Analyst
    Earlier today, XOMA Corporation (NASDAQ: XOMA) acquired the royalty and milestone rights associated with two assets from LadRx Corporation: arimoclomol for Niemann-Pick disease type C, and... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
      Wednesday saw 59 companies set new 52-week lows. 
    Via Benzinga
    Recap: XOMA Q1 Earnings
    XOMA (NASDAQ:XOMA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:30 AM. Here's what investors need to know about the announcement. Earnings XOMA missed estimated earnings by 96.0%,... 
    Via Benzinga
    XOMA: Q1 Earnings Insights
    XOMA (NASDAQ:XOMA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:30 AM. Here's what investors need to know about the announcement. Earnings XOMA missed estimated earnings by 96.0%,... 
    Via Benzinga
    XOMA: Q3 Earnings Insights
    XOMA (NASDAQ:XOMA) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:45 AM. Here's what investors need to know about the announcement. Earnings XOMA missed estimated earnings by... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Thursday
      On Thursday, 168 companies reached new 52-week lows. 
    Via Benzinga
    XOMA Earnings Perspective: Return On Capital Employed
    Benzinga Pro data, XOMA (NASDAQ:XOMA) reported Q1 sales of $3.11 million. Earnings fell to a loss of $2.28 million, resulting in a 107.64% decrease from last quarter. In Q4, XOMA earned $29.84 million,... 
    Via Benzinga
    XOMA's Return On Capital Employed Insights
    According to Benzinga Pro, during Q4, XOMA (NASDAQ:XOMA) earned $29.84 million, a 772.77% increase from the preceding quarter. XOMA also posted a total of $35.94 million in sales... 
    Via Benzinga
    50 Biggest Movers From Yesterday
    Gainers Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares surged 63.7% to settle at $2.21 on Wednesday after the company announced that in preclinical studies its lead... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
    During Wednesday's trading, 435 companies set new 52-week lows. 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Gainers Lixte Biotech Holdings (NASDAQ:LIXT) stock increased by 70.4% to $2.3 during Wednesday's regular session. Trading volume for this security as of 12:31 EST is... 
    Via Benzinga
    XOMA's Return On Capital Employed Overview
    Benzinga Pro data, XOMA (NASDAQ:XOMA) reported Q3 sales of $940.00 thousand. Earnings fell to a loss of $3.35 million, resulting in a 9.17% decrease from last quarter. In Q2,... 
    Via Benzinga
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.